CasLoc logo
All Cases PTAB Litigations UPC Oppositions
The patent has been granted The patent has been granted, Grant of patent is intended, Examination is in progress, Request for examination was made, The international publication has been made, unknown EP Register Verified

HYDROLYSED COLLAGEN FOR USE IN IN AMELIORATING HYPERGLYCAEMIA OR A RISK FACTOR FOR HYPERGLYCAEMIA AND METHOD FOR OBTAINING IT

Publication No. EP4498839
•
App No. EP23730777
•
Filed by Rousselot BV
•
Filed on 2023-06-02
•
Issued/Published on 2025-12-17
Publication No. EP4498839 A1
Application No. EP23730777 Filed: 2023-06-02
Grant Date 2025-12-17 Mention of grant
Active Oppositions 1 Active EPO Oppositions

Patent Abstract / Summary

Patent abstract is being processed or was not provided in English by the publishing office.

IPC Classifications

A61K38/01, A23L33/18, A61P3/10, A61K38/39, A23L33/28 A23L33/18, A61P3/10, A61K38/39, A23L33/28

Priority Claims

BE 20220005427 Date: 2022-06-02

Designated Contracting States (39 EPC States)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

Parties & Representation

Applicants

Rousselot BV

Meulestedekaai 81, 9000 Gent

BE

Inventors (5)

CALLEMIN, Kristof Robert

9000 GENT

BE

GEVAERT, Elien Monique

9000 GENT

BE

GOES, Arne

9000 GENT

BE

PRAWITT, Janne

9000 GENT

BE

VLEMINCKX, Sara

9000 GENT

BE

Representatives / Agents

EP&C

P.O. Box 3241, 2280 GE Rijswijk

NL

Hoeger, Stellrecht & Partner Patentanwälte mbB

Uhlandstrasse 14c, 70182 Stuttgart

DE

Key Procedural Dates

Request-For-Examination 2024-10-29
Mention Of Grant Published 2025-12-17
First-Examination-Report-Despatched 2025-03-25